Testing effectiveness (Phase 2)Looking for participantsNCT07777861
What this trial is testing
A Phase II Trial of G01 Eye Drops for Glaucomatous Optic Neuropathy
Who this might be right for
Primary Open-Angle GlaucomaOptic Nerve Injury
Qingdao WanMing BioCell Pharmaceutics Co.,Ltd. 90